What is Applied Science?
Applied Science operates at the intersection of medical technology and operational efficiency, providing transformative solutions for the blood collection industry and chronic care management. The company's flagship HemoFlow platform serves as a cornerstone of its portfolio, automating whole blood collection processes to drive phlebotomist productivity and minimize clinical errors through enhanced operational intelligence. Beyond blood collection, the firm addresses the complexities of value-based care via its AdaptivMD platform, which facilitates remote patient monitoring and chronic care management. By focusing on underserved populations, Applied Science demonstrates a commitment to health equity, effectively partnering with healthcare providers to improve patient outcomes while maintaining high customer retention rates in a demanding sector.
How much funding has Applied Science raised?
Applied Science has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Applied Science
PPP
Public-Private Partnership
What's next for Applied Science?
With the successful closure of this late-stage financing, Applied Science is poised to scale its operational footprint and deepen its penetration into the value-based care market. The strategic deployment of this capital will likely focus on expanding the reach of the AdaptivMD platform, enabling broader access to remote monitoring for chronic conditions. Furthermore, the company is expected to invest in R&D to refine its HemoFlow automation capabilities, ensuring that its technological offerings remain at the forefront of clinical efficiency. As the healthcare industry continues to prioritize digital transformation and patient-centric models, Applied Science is strategically aligned to capitalize on these trends, potentially exploring new partnerships or market segments that require robust, data-driven healthcare solutions.
See full Applied Science company page
